Berlin, Germany

Manfred Albring


Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 79(Granted Patents)


Company Filing History:


Years Active: 1982-1990

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Manfred Albring: Innovator in Pharmaceutical Chemistry

Introduction

Manfred Albring is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative steroid compounds. With a total of 5 patents to his name, Albring's work has had a lasting impact on medical science.

Latest Patents

Among his latest patents, Albring has developed antiandrogenic 17-alpha-alkyl steroids. These compounds are characterized by the formula ##STR1##, wherein R.sub.1 can be hydrogen, acyl, alkyl, alkenyl, or other specified groups. Additionally, he has worked on a Nifedipine combination preparation, showcasing his expertise in creating effective pharmaceutical formulations.

Career Highlights

Albring is currently associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at Schering has allowed him to focus on innovative solutions that address various medical challenges. His contributions have been instrumental in advancing therapeutic options for patients.

Collaborations

Throughout his career, Albring has collaborated with esteemed colleagues such as Rudolf Wiechert and Dieter Bittler. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.

Conclusion

Manfred Albring's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of new therapeutic agents, making a significant impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…